Fig. 3From: Establishment and validation of a prognostic risk classification for patients with stage T1-3N0M0 esophageal squamous cell carcinomaApplication of Esorisk to refine the risk assessment in patients with esophageal squamous cell cancer in different stages. These included stage T1N0M0 (A), stage T2N0M0 (B), and stage T3N0M0 (C)Back to article page